Trade

with

China Biologic Products Inc
(NASDAQ: CBPO)
AdChoices
55.95
+1.27
+2.32%
After Hours :
55.90
-0.05
-0.09%

Open

56.20

Previous Close

54.68

Volume (Avg)

85.30k (44.81k)

Day's Range

54.68-56.20

52Wk Range

26.66-58.00

Market Cap.

1.37B

Dividend Rate ( Yield )

-

Beta

1.65

Shares Outstanding

24.48M

P/E Ratio (EPS)

23.92 (2.34)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 203.36M

    • Net Income

    • 54.60M

    • Market Cap.

    • 1.37B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 29.01

    • PEG (Price/Earnings Growth) Ratio

    • 1.10

    • Beta

    • 1.65

    • Forward P/E

    • 17.76

    • Price/Sales

    • 6.94

    • Price/Book Value

    • 6.59

    • Price/Cash flow

    • 18.15

      • EBITDA

      • 101.00M

      • Return on Capital %

      • 15.32

      • Return on Equity %

      • 27.70

      • Return on Assets %

      • 15.32

      • Book Value/Share

      • 8.49

      • Shares Outstanding

      • 24.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 59.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • 4.02

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 12.10

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • 20.70

          • 17.04

          • Net Income

            Q/Q (last year)

          • 22.00

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 34.18

          • 63.43

          • Net Income

            5-Year Annual Average

          • 35.40

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 67.29

            • 82.75

            • Pre-Tax Margin

            • 47.01

            • 39.38

            • Net Profit Margin

            • 29.01

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 70.40

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 37.50

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 17.40

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.34

              • 0.76

              • Current Ratio

              • 3.05

              • 2.92

              • Quick Ratio

              • 1.49

              • 2.35

              • Interest Coverage

              • 46.65

              • 38.02

              • Leverage Ratio

              • 2.16

              • 2.21

              • Book Value/Share

              • 8.49

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 22.22

                • 217.39

                • P/E Ratio 5-Year High

                • 24.80

                • 634.30

                • P/E Ratio 5-Year Low

                • 2.55

                • 124.82

                • Price/Sales Ratio

                • 6.45

                • 9.52

                • Price/Book Value

                • 6.13

                • 8.61

                • Price/Cash Flow Ratio

                • 18.15

                • 50.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 27.70

                    (22.60)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • 15.32

                    (11.30)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • 20.30

                    (18.40)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • 40.13k

                  • 117.08k

                  • Inventory Turnover

                  • 0.79

                  • 1.48

                  • Asset Turnover

                  • 0.53

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  86.93M
                  Operating Margin
                  42.75
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  18.15
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  109.65%

                  Mutual Fund Ownership

                  4.45%

                  Float

                  40.36%

                  5% / Insider Ownership

                  33.28%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Swedbank Robur Medica

                  •  

                    301,515

                  • 15.37

                  • 1.24

                  • Fidelity® China Region Fund

                  •  

                    117,600

                  • -24.88

                  • 0.48

                  • ZI Fidelity Pacific

                  •  

                    110,054

                  • 0.06

                  • 0.45

                  • Fidelity China Special Situations PLC

                  •  

                    83,659

                  • 117.17

                  • 0.35

                  • Robeco Chinese Equities

                  •  

                    80,658

                  • 0.00

                  • 0.33

                  • PowerShares Golden Dragon China Port

                  •  

                    74,297

                  • 0.00

                  • 0.31

                  • Columbia Greater China Fund

                  •  

                    43,013

                  • 0.00

                  • 0.18

                  • Robeco Asian Stars Equities

                  •  

                    40,390

                  • 188.50

                  • 0.16

                  • BlackRock Small Cap Growth Equity Port

                  •  

                    30,363

                  • 0.00

                  • 0.12

                  • Columbia Pacific/Asia Fund

                  •  

                    27,926

                  • 0.00

                  • 0.11

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Warburg Pincus LLC

                  •  

                    10,989,200

                  • 0.00%

                  • 46.64

                  • Visium Asset Management LLC

                  •  

                    388,609

                  • +769.88%

                  • 1.65

                  • Swedbank Robur Fonder AB

                  •  

                    301,515

                  • +15.37%

                  • 1.24

                  • Morgan Stanley & Co Inc

                  •  

                    203,273

                  • +573.40%

                  • 0.86

                  • Renaissance Technologies Corp

                  •  

                    200,100

                  • +53.48%

                  • 0.85

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Aggressive Growth

                  Style

                  Small Growth

                  China Biologic Products, Inc. was originally incorporated on December 20, 1989 under the laws of the State of Texas as Shepherd Food Equipment, Inc. On November 20, 2000, Shepherd Food Equipment, Inc. changed its corporate name to Sh...moreepherd Food Equipment, Inc. Acquisition Corp., which is the survivor of a merger with GRC Holdings, Inc. on May 28, 2003. On January 10, 2007, the Company was converted into a Delaware corporation and changed its name to China Biologic Products, Inc. It is a biopharmaceutical company which is engaged in the research, development, manufacturing and sales of human plasma-based pharmaceutical products in China. The Company has two majority subsidiaries, Shandong Taibang, a company based in Tai’an, Shandong Province and Guizhou Taibang, a company based in Guiyang, Guizhou Pr...moreovince. The Company’s products are human albumin and immunoglobulin products. Albumin has been used for almost 50 years to treat critically ill patients by replacing lost fluid and maintaining adequate blood volume and pressure. Immunoglobulin is used for certain disease prevention and treatment by enhancing specific immunity. These products use human plasma as the principal raw material. Human albumin and human immunoglobulin for intravenous injection, or IVIG products, are the top-selling products. The Company sells its products primarily to hospitals and inoculation centers in the PRC directly or through approved distributors.lessless

                  Key People

                  David (Xiaoying) Gao

                  CEO/Chairman of the Board/Director/President

                  Mr. Ming Yang

                  CFO/Chief Accounting Officer

                  Ms. Zhijing Liu

                  Vice President

                  Gang Yang

                  General Manager, Subsidiary/Vice President

                  Mr. Sean Shao

                  Director

                  • China Biologic Products Inc

                  • 18th Floor

                  • Beijing, 100125

                  • USA.Map

                  • Phone: +86 1065983111

                  • Fax: +86 1065983222

                  • ctbb.com.cn

                  Incorporated

                  1989

                  Employees

                  1,533

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: